BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16469658)

  • 1. Treatment of adductor spasmodic dysphonia with selective laryngeal adductor denervation and reinnervation surgery.
    Chhetri DK; Berke GS
    Otolaryngol Clin North Am; 2006 Feb; 39(1):101-9. PubMed ID: 16469658
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional reinnervation of vocal folds after selective laryngeal adductor denervation-reinnervation surgery for spasmodic dysphonia.
    DeConde AS; Long JL; Armin BB; Berke GS
    J Voice; 2012 Sep; 26(5):602-3. PubMed ID: 22516313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia.
    Berke GS; Blackwell KE; Gerratt BR; Verneil A; Jackson KS; Sercarz JA
    Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):227-31. PubMed ID: 10086613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective denervation: reinnervation for the control of adductor spasmodic dysphonia.
    Allegretto M; Morrison M; Rammage L; Lau DP
    J Otolaryngol; 2003 Jun; 32(3):185-9. PubMed ID: 12921138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngeal framework surgery in the management of spasmodic dysphonia. Preliminary report.
    Tucker HM
    Ann Otol Rhinol Laryngol; 1989 Jan; 98(1 Pt 1):52-4. PubMed ID: 2910189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems with surgical (RLN section) treatment of spastic dysphonia.
    Dedo HH; Izdebski K
    Laryngoscope; 1983 Mar; 93(3):268-71. PubMed ID: 6834947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral thyroarytenoid denervation: a new treatment for laryngeal hyperadduction disorders studied in the canine.
    Sercarz JA; Berke GS; Ming Y; Rothschiller J; Graves MC
    Otolaryngol Head Neck Surg; 1992 Nov; 107(5):657-68. PubMed ID: 1437204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of denervation on laryngeal muscles: a canine model.
    Shindo ML; Herzon GD; Hanson DG; Cain DJ; Sahgal V
    Laryngoscope; 1992 Jun; 102(6):663-9. PubMed ID: 1534862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.
    Genack SH; Woo P; Colton RH; Goyette D
    Otolaryngol Head Neck Surg; 1993 Mar; 108(3):256-64. PubMed ID: 8464639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up results of selective laryngeal adductor denervation-reinnervation surgery for adductor spasmodic dysphonia.
    Chhetri DK; Mendelsohn AH; Blumin JH; Berke GS
    Laryngoscope; 2006 Apr; 116(4):635-42. PubMed ID: 16585872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.
    Tsuji DH; Chrispim FS; Imamura R; Sennes LU; Hachiya A
    Braz J Otorhinolaryngol; 2006; 72(2):261-6. PubMed ID: 16951863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures for the selection of spastic dysphonia patients for recurrent laryngeal nerve section.
    Ludlow CL; Naunton RF; Bassich CJ
    Otolaryngol Head Neck Surg; 1984 Feb; 92(1):24-31. PubMed ID: 6422412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Judgment of voice improvement after recurrent laryngeal nerve section for spastic dysphonia: clinicians versus patients.
    Sapir S; Aronson AE; Thomas JE
    Ann Otol Rhinol Laryngol; 1986; 95(2 Pt 1):137-41. PubMed ID: 3516048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of glial-derived neurotrophic factor in rat laryngeal muscles during reinnervation.
    Hernandez-Morato I; Isseroff TF; Sharma S; Pitman MJ
    Laryngoscope; 2014 Dec; 124(12):2750-6. PubMed ID: 25220603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngeal reinnervation.
    Rice DH
    Laryngoscope; 1982 Sep; 92(9 Pt 1):1049-59. PubMed ID: 7121159
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia.
    Netterville JL; Stone RE; Rainey C; Zealear DL; Ossoff RH
    Ann Otol Rhinol Laryngol; 1991 Jan; 100(1):10-4. PubMed ID: 1985522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transoral approach to laser thyroarytenoid myoneurectomy for treatment of adductor spasmodic dysphonia: short-term results.
    Su CY; Chuang HC; Tsai SS; Chiu JF
    Ann Otol Rhinol Laryngol; 2007 Jan; 116(1):11-8. PubMed ID: 17305272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study on delayed reinnervation of vocal cord adductors].
    Zheng H; Li Z; Zhou S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(4):218-20. PubMed ID: 7803121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.